|Linked Problems & Solutions
HERhealthEQ and Lutech Medical are donating 100 Lutech LT-300 colposcopes to local community-based healthcare clinics in 10 countries (including Costa Rica, Egypt, Fiji, Ghana, Lebanon, Mexico, Romania, South Africa, Zambia, and more). This project will screen 500,000 women for cervical cancer in just two years. When fully deployed, the program will have an impact of more than 450,000 women each year.
According to the World Health Organization, cervical cancer is the fourth most frequent cancer in women worldwide, and about 90% of cervical cancer diagnoses occur in low- and middle-income countries. When cervical cancer is not detected early, the survival rate is 66%. This can drop as low as 40% in parts of sub-Saharan Africa. If cervical cancer is detected early, the survival rate is 92%.
HERhealthEQ's 10-for-10 Project will screen 500,000 women for cervical cancer per year.